Immunogenicity 11762
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
MMEL1
Transcript ID
uc001ajy.2
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (779 aa)
MGKSE
1
GPVGM
6
VESAG
11
RAGQK
16
RPGFL
21
EGGLL
26
LLLLL
31
VTAAL
36
VALGV
41
LYADR
46
RGKQL
51
PRLAS
56
RLCFL
61
QEERT
66
FVKRK
71
PRGIP
76
EAQEV
81
SEVCT
86
TPGCV
91
IAAAR
96
ILQNM
101
DPTTE
106
PCDDF
111
YQFAC
116
GGWLR
121
RHVIP
126
ETNSR
131
YSIFD
136
VLRDE
141
LEVIL
146
KAVLE
151
NSTAK
156
DRPAV
161
EKART
166
LYRSC
171
MNQSV
176
IEKRG
181
SQPLL
186
DILEV
191
VGGWP
196
VAMDR
201
WNETV
206
GLEWE
211
LERQL
216
ALMNS
221
QFNRR
226
VLIDL
231
FIWND
236
DQNSS
241
RHIIY
246
IDQPT
251
LGMPS
256
REYYF
261
NGGSN
266
RKVRE
271
AYLQF
276
MVSVA
281
TLLRE
286
DANLP
291
RDSCL
296
VQEDM
301
VQVLE
306
LETQL
311
AKATV
316
PQEER
321
HDVIA
326
LYHRM
331
GLEEL
336
QSQFG
341
LKGFN
346
WTLFI
351
QTVLS
356
SVKIK
361
LLPDE
366
EVVVY
371
GIPYL
376
QNLEN
381
IIDTY
386
SARTI
391
QNYLV
396
WRLVL
401
DRIGS
406
LSQRF
411
KDTRV
416
NYRKA
421
LFGTM
426
VEEVR
431
WRECV
436
GYVNS
441
NMENA
446
VGSLY
451
VREAF
456
PGDSK
461
SMVRE
466
LIDKV
471
RTVFV
476
ETLDE
481
LGWMD
486
EESKK
491
KAQEK
496
AMSIR
501
EQIGH
506
PDYIL
511
EEMNR
516
RLDEE
521
YSNLN
526
FSEDL
531
YFENS
536
LQNLK
541
VGAQR
546
SLRKL
551
REKVD
556
PNLWI
561
IGAAV
566
VNAFY
571
SPNRN
576
QIVFP
581
AGILQ
586
PPFFS
591
KEQPQ
596
ALNFG
601
GIGMV
606
IGHEI
611
THGFD
616
DNGRN
621
FDKNG
626
NMMDW
631
WSNFS
636
TQHFR
641
EQSEC
646
MIYQY
651
GNYSW
656
DLADE
661
QNVNG
666
FNTLG
671
ENIAD
676
NGGVR
681
QAYKA
686
YLKWM
691
AEGGK
696
DQQLP
701
GLDLT
706
HEQLF
711
FINYA
716
QVWCG
721
SYRPE
726
FAIQS
731
IKTDV
736
HSPLK
741
YRVLG
746
SLQNL
751
AAFAD
756
TFHCA
761
RGTPM
766
HPKER
771
CRVW
776
Mutation Information
DNA mutation:
None
Peptide Range:
381 ~ 405
Mut AA position:
393 (13 in Wild Type peptide)
Alignment
Wild Type:
"QNLENIIDTYSARTIQNYLVWRLVL
||||||||||||.||||||||||||
Mutant:
QNLENIIDTYSAKTIQNYLVWRLVL"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) MMEL1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay